{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "CLOSED", "regularMarketChangePercent": 0.67114353, "regularMarketPrice": 15.0, "exchange": "MIL", "shortName": "PHILOGEN", "longName": "Philogen S.p.A.", "messageBoardId": "finmb_26146436", "exchangeTimezoneName": "Europe/Rome", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "it_market", "esgPopulated": false, "regularMarketTime": 1683905701, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.13, "sharesOutstanding": 40361300, "bookValue": 3.371, "fiftyDayAverage": 15.4216, "fiftyDayAverageChange": -0.42160034, "fiftyDayAverageChangePercent": -0.0273383, "twoHundredDayAverage": 14.5505, "twoHundredDayAverageChange": 0.44950008, "twoHundredDayAverageChangePercent": 0.030892415, "marketCap": 607438528, "priceToBook": 4.449718, "sourceInterval": 20, "exchangeDataDelayedBy": 15, "averageAnalystRating": "3.0 - Hold", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1614758400000, "priceHint": 2, "regularMarketChange": 0.10000038, "regularMarketDayHigh": 15.0, "regularMarketDayRange": "14.8 - 15.0", "regularMarketDayLow": 14.8, "regularMarketVolume": 3120, "regularMarketPreviousClose": 14.9, "bid": 14.8, "ask": 14.55, "fullExchangeName": "Milan", "financialCurrency": "EUR", "regularMarketOpen": 15.0, "averageDailyVolume3Month": 9526, "averageDailyVolume10Day": 5384, "fiftyTwoWeekLowChange": 2.0, "fiftyTwoWeekLowChangePercent": 0.15384616, "fiftyTwoWeekRange": "13.0 - 16.76", "fiftyTwoWeekHighChange": -1.7600002, "fiftyTwoWeekHighChangePercent": -0.10501195, "fiftyTwoWeekLow": 13.0, "fiftyTwoWeekHigh": 16.76, "symbol": "PHIL.MI"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Via Bellaria, 35", "city": "Sovicille", "state": "SI", "zip": "53018", "country": "Italy", "phone": "39 0577 17816", "fax": "39 05771 78 16 80", "website": "https://www.philogen.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Philogen S.p.A., a biotechnology company, develops drugs for oncology and chronic inflammatory diseases. It is developing Nidlegy, a combination of the immunocytokines L19IL2 and L19TNF developed intralesional treatment for locoregional melanoma and non-melanoma skin cancers; Fibromun, a human immunomodulatory product consisting of L19 antibody and TNF to treat soft tissue sarcoma, leiomyosarcoma, and glioma; and Darleukin (L19IL2), a human immunostimulatory product consisting of the human L19 antibody fused to the human cytokine interleukin-2 (IL2), which is in phase II clinical trial for the treatment of non-small cell lung cancer. The company is also developing Dodekin, a human immunostimulatory product that comprises vascular targeting antibody fused to interleukin-12 that is in phase I/II clinical trial to treat advanced solid tumors; Dekavil (F8IL10), an anti-inflammatory product, which is in phase I clinical trial for the treatment of chronic inflammation; Onco IX (PHC-102), a 99mTc labelled small molecule radiotracer for the non-invasive detection of carbonic anhydrase IX (CAIX) expressing solid tumors that is in phase 1 clinical trial; and OncoFAP, a small molecule radiotracer for the non-invasive detection of various metastatic solid tumors targeting fibroblast activation protein, which is in phase 1 clinical trial. Philogen S.p.A. was founded in 1996 and is based in Sovicille, Italy.", "fullTimeEmployees": 157, "companyOfficers": [{"maxAge": 1, "name": "Dr. Duccio  Neri", "title": "Co-Founder & Exec. Chairman", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Dario  Neri Ph.D.", "age": 59, "title": "Co-Founder, CEO , MD, CSO, Pres of the Scientific Advisory Board & Director", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Giovanni  Neri", "title": "Co-Founder, Head of IP & Licensing", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Laura  Baldi", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Alfredo  Covelli M.D.", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Katia  Lorizzo", "title": "Deputy CMO & Head of Clinical Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}